Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangming Li

Showing results (421-430 of 440) with videos related to

Pageof 44
Sort By:
Journal of Viral Hepatitis|January 26, 2022
Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open-label, phase 2 studyRui Hua, Fei Kong, Xiaofeng Wen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 18, 2024
The Absence of Intra-Tumoral Tertiary Lymphoid Structures is Associated with a Worse Prognosis and mTOR Signaling Activation in Hepatocellular Carcinoma with Liver Transplantation: A Multicenter Retrospective StudyJianhua Li, Li Zhang, Hao Xing, et al.
Clinical and Translational Medicine|May 18, 2026
A multi-centre, prospective trial of a methylation-based liquid biopsy for early detection of liver cancer in high-risk populationsRuohan Zhang, Xinrong Yang, Guangming Li, et al.
International Journal of Surgery (London, England)|December 11, 2025
Chinese guidelines for minimally invasive surgery in liver transplant recipients (2025)Xufeng Zhang, Lin Wei, Junxi Xiang, et al.
Signal Transduction and Targeted Therapy|January 17, 2025
Real-world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort studyHaiyu Wang, Guangying Cui, Ming Cheng, et al.
Plos Pathogens|January 5, 2022
Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized miceCatarina E Hioe, Guangming Li, Xiaomei Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 13, 2020
Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trialYanhang Gao, Fei Kong, Guangming Li, et al.
Blood|June 5, 2026
High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemiaGianpietro Dotti, Tara Walhart, Marta Biondi, et al.
Journal of Gastroenterology and Hepatology|January 25, 2021
Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single-arm, open-label, phase 3 trialFei Kong, Xiaoyu Wen, Xiaofeng Wen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 22, 2025
Efficacy and Safety of HSK31679 in Asian Patients with MASLD: A Randomized Controlled TrialFeng Xue, Wei Ma, Jixian Gao, et al.
Pageof 44

Showing results (421-430 of 440) with videos related to

Sort By:
Pageof 44
Journal of Viral Hepatitis|January 26, 2022
Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open-label, phase 2 studyRui Hua, Fei Kong, Xiaofeng Wen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 18, 2024
The Absence of Intra-Tumoral Tertiary Lymphoid Structures is Associated with a Worse Prognosis and mTOR Signaling Activation in Hepatocellular Carcinoma with Liver Transplantation: A Multicenter Retrospective StudyJianhua Li, Li Zhang, Hao Xing, et al.
Clinical and Translational Medicine|May 18, 2026
A multi-centre, prospective trial of a methylation-based liquid biopsy for early detection of liver cancer in high-risk populationsRuohan Zhang, Xinrong Yang, Guangming Li, et al.
International Journal of Surgery (London, England)|December 11, 2025
Chinese guidelines for minimally invasive surgery in liver transplant recipients (2025)Xufeng Zhang, Lin Wei, Junxi Xiang, et al.
Signal Transduction and Targeted Therapy|January 17, 2025
Real-world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort studyHaiyu Wang, Guangying Cui, Ming Cheng, et al.
Plos Pathogens|January 5, 2022
Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized miceCatarina E Hioe, Guangming Li, Xiaomei Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 13, 2020
Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trialYanhang Gao, Fei Kong, Guangming Li, et al.
Blood|June 5, 2026
High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemiaGianpietro Dotti, Tara Walhart, Marta Biondi, et al.
Journal of Gastroenterology and Hepatology|January 25, 2021
Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single-arm, open-label, phase 3 trialFei Kong, Xiaoyu Wen, Xiaofeng Wen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 22, 2025
Efficacy and Safety of HSK31679 in Asian Patients with MASLD: A Randomized Controlled TrialFeng Xue, Wei Ma, Jixian Gao, et al.
Pageof 44